deltatrials
Completed PHASE3 NCT00000550

Rapid Early Action for Coronary Treatment (REACT)

Sponsor: Carelon Research

Conditions Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Infarction Myocardial Ischemia
Interventions health education
Updated 7 times since 2017 Last updated: Mar 3, 2014 Started: Aug 31, 1994 Primary completion: May 31, 2000 Completion: May 31, 2000

A PHASE3 clinical study on Cardiovascular Diseases and Coronary Disease, this trial is completed. The trial is conducted by Carelon Research and has accumulated 7 data snapshots since 1994. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Aug 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Aug 2023 [monthly]

    Completed PHASE3

  5. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Jun 2018 — Apr 2020 [monthly]

    Completed PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Aug 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Carelon Research
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: Carelon Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.